In 2023, Jyoti and Bharat Patel of west London became part of an NHS trial using smart sensors, mattresses, and wearable tech to monitor dementia progression, with costs expected at £2,000 annually and hopes to delay hospital visits. A study published in PMC found global dementia healthcare spending rose 4.5% annually from 2000 to 2019, reaching $263 billion in 2019, with projections of $1.6 trillion by 2050 under a baseline scenario.
Jyoti Patel, diagnosed with dementia in 2021, now lives in a west London home equipped with sensors that track her movements, sleep, and daily routines as part of a UK Dementia Research Institute (UK DRI) trial. The system includes smart mattresses, motion sensors, and wearable devices like smart socks and a temperature-monitoring watch, all designed to detect early signs of health changes. Bharat, her husband, said the technology provides “peace of mind,” though concerns about data privacy remain. The trial, funded by LifeArc, involves over 250 families, according to the BBC.
The Technology Behind the Trial
The Patels’ home is fitted with door sensors to detect nighttime wandering, kitchen appliances that monitor meal consumption, and a smart mattress that tracks heart rate, breathing, and sleep disturbances. These devices, connected to a network, send data to a team of doctors and specialists who analyze patterns to anticipate health declines. Earlier signals means earlier intervention,
said Sarah Daniels, health and social care lead at UK DRI, emphasizing that the goal is to head off potential complications of an infection, potential challenges around care, we can head that off before it becomes a crisis.
Smart socks and a specialized watch monitor Jyoti’s body temperature and gait, indicators of frailty. Even if it can cut down my worries by 5 or 10%, then it helps me and it will help other people too,
Bharat said. The system does not record audio or video, but some participants may still feel uneasy about the data shared with healthcare providers. A study noted that dementia care costs could represent 11% of global health spending by 2050, with some scenarios projecting up to 17%.
A Personal Journey and Early Signs
Jyoti was diagnosed with Alzheimer’s in 2021 after Bharat noticed uncharacteristic mistakes during their magic performances. Normally she used to set my stage up and everything was perfect, but I saw something I was looking for and it wasn’t there,
he said. He recalled her confusion during walks, where she would find that she was lost
without realizing it. I didn’t know it [was] dementia but I knew it was something which [was] unusual,
he added.
The couple, who met in 1977 and performed globally as magicians, now rely on the technology to maintain Jyoti’s independence. The main aim, she says, is to give earlier signals to health and social care professionals,
Daniels said. The trial, funded by LifeArc, involves over 250 families and aims to reduce preventable hospital visits, a growing concern as dementia cases in the UK are projected to rise 40% by 2040. A study estimated that global dementia healthcare spending reached $594 billion in 2019, with attributable spending projected to hit $1.6 trillion by 2050.
Costs, Privacy, and the Road Ahead
The annual cost of the technology is estimated at £2,000, covering monitoring and data analysis by healthcare staff. While critics question whether this is no more than a couple of weeks in a care home,
NHS England’s Dr. Jeremy Isaacs noted the trial builds on existing programs to support aging at home. The number of people with dementia in the UK is expected to climb by another 40% by 2040,
Daniels said, advocating for wider adoption. A study highlighted that dementia care could consume 11% of global health spending by 2050, with some scenarios projecting up to 17%.
The trial’s success could redefine dementia care, balancing innovation with ethical considerations. As the NHS monitors outcomes, the Patels’ experience highlights both the promise and challenges of integrating technology into long-term health management. A study underscored the urgency of addressing dementia’s financial burden, noting that global spending on dementia care is projected to rise sharply, with significant implications for healthcare systems worldwide.